Latest Breaking News On - Cardiff oncology daily - Page 2 : comparemela.com

HC Wainwright Raises Cardiff Oncology (NASDAQ:CRDF) Price Target to $14 00

Cardiff Oncology (NASDAQ:CRDF – Free Report) had its target price hoisted by HC Wainwright from $12.00 to $14.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Cardiff Oncology’s Q1 2024 earnings at ($0.23) EPS, Q2 2024 earnings at […]

United statesPiper sandlerRenaissance technologiesCardiff oncology incSecurities exchange commissionCitigroup incWalleye capitalVanguard group incCardiff oncologyFree reportDirector garyExchange commissionGate managerGet free reportPolo like kinaseCardiff oncology daily

Gary W Pace Acquires 30,000 Shares of Cardiff Oncology, Inc (NASDAQ:CRDF) Stock

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) Director Gary W. Pace acquired 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The shares were bought at an average cost of $1.37 per share, for a total transaction of $41,100.00. Following the transaction, the director now owns 697,761 shares […]

United statesAmerica corpPricet rowe associates incWalleye capitalCardiff oncology incDimensional fund advisorsSecurities exchange commissionTopco ltdCardiff oncologyGet free reportDirector garyExchange commissionFund advisorsPolo like kinaseCardiff oncology dailyNasdaq crdf

Insider Buying: Cardiff Oncology, Inc (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock

Insider Buying: Cardiff Oncology, Inc (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesDimensional fund advisorsCardiff oncology incCardiff oncology company profileWalleye capitalTopco ltdPricet rowe associates incAmerica corpCardiff oncologyGet free reportDirector garyFund advisorsPolo like kinaseCardiff oncology daily

Cardiff Oncology, Inc (NASDAQ:CRDF) Short Interest Down 9 4% in November

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 1,450,000 shares, a decrease of 9.4% from the November 15th total of 1,600,000 shares. Based on an average daily trading volume, of 688,500 shares, the short-interest […]

United statesRenaissance technologiesCardiff oncology incCardiff oncology company profileBlackrock incVanguard group incCitigroup incCardiff oncologyGet free reportStreet corpPolo like kinaseCardiff oncology dailyNasdaq crdf

Cardiff Oncology, Inc (NASDAQ:CRDF) Short Interest Down 24 6% in October

Cardiff Oncology, Inc (NASDAQ:CRDF) Short Interest Down 24 6% in October
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesCardiff oncology incRenaissance technologiesCardiff oncology company profileCitigroup incVanguard group incBlackrock incCardiff oncologyGet free reportStreet corpPolo like kinaseCardiff oncology daily